PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
September 15, 2024Cancer Research

Abstract B027: A blood-based, multiplex protein biomarker signature shows superior performance in detection of early-stage pancreatic ductal adenocarcinoma (PDAC)

View Full Paper
Ask AI
Bookmark
Share

Authors

NPNorma Alonzo PalmaRSRalph SchiessTKThomas C. King

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Palma et al. (2024) studied this question.

synapsesocial.com/papers/68e587f9b6db643587524434https://doi.org/10.1158/1538-7445.pancreatic24-b027
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of a multi-analyte blood test for the early detection of pancreatic ductal adenocarcinoma (PDAC) and performance compared to CA19-9.2024
  2. 2Abstract B063: Immune cell expression-based multi-biomarker blood panel for early detection of pancreatic ductal adenocarcinoma2025
  3. 3B-340 Validation of a five-biomarker test in serum for detection of early-stage pancreatic ductal adenocarcinoma2025
  4. 4Abstract 4075: Enhanced early detection of pancreatic cancer using a multi-analyte liquid biopsy approach2026 · 1 citations
  5. 5Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups2026